Sanofi iAwards North America

What Is It?

Sanofi is committed to collaborating with partners to advance cutting-edge discoveries into transformative medicines that improve patient lives. The Sanofi Innovation Awards (iAwards) program, created in 2015, was designed to do just that. More than 28 top academic and medical centers in North America participate in this program to advance innovations in target identification and translational science into first-in-class therapeutic solutions.

About the Program

  • Seed funding of $150.000 USD
  • Dedicated Sanofi Project Champion and resources (subject matter experts)
  • A steppingstone to further collaboration

Who Are We Looking For?

Principal investigators from academic partner institutions developing cutting-edge therapeutic solutions in the following areas: 

  • Immuno- and molecular-oncology
  • Immunology and inflammatory diseases 
  • Rare and neurological diseases 
  • Genomic medicine 
  • Precision medicine 
  • New therapeutic modalities

Next Call for Projects: April 22nd 2024

Only principal investigators belonging to one of the iAwards partner institutions are eligible to this call. For more information, please contact

Our Selection Process

A fast process to select and start projects in less than 8 months

Week 0

Call launch

+8 Weeks

Pre-proposal submission

+4 Weeks

Pre-selection by Sanofi experts

+6 Weeks

Detailed proposal submission

+4 Weeks

Final selection by Sanofi experts

+8 Weeks

Projects kick-off


"I am pleased by the continued partnership between the Perelman School of Medicine at the University of Pennsylvania and Sanofi, in particular the success of the Sanofi iAwards. Our investigators" appreciate the opportunity to collaborate with Sanofi scientists and leadeership on cutting-edge, scientific ideas - advancing the innovative work from concept to application. As a JSSC member, I am delighted to foster this partnership and support the program's grouwth, not only at Penn, but accorss the U.S."

Jonathan A. Epstein, M.D., Executive Vice Dean and Chief Scientific Officer, WIlliam Wikoff Smith Professor of MEdicine, Perelman School of Medecine at the University of Pennsylvania, Sanofi iAwards External Joint Scientific Steering Commitee Member

iAward Recipients for the 2022 Cycle

Changning Wang

Mass General Hospital

Francesca Bartolini

Columbia University

Nikolas Patsoukis

Beth Israel Deaconess Medical Center

Casey Maguire

Mass General Hospital

Eric Smith

Dana Farber Cancer Institute

Joe Zhou

Weill Cornell Medicine

Jonathan Schneck

Johns Hopkins Medicine

Daniel Tenen

Beth Israel Deaconess Medical Center

Rohit Chandwani

Weill Cornell Medicine

iAward Program Partners

  • Beth Israel Deaconess Medical Center
  • Boston Children’s Hospital
  • Brigham and Woman’s Hospital
  • California Institute of Technology
  • Cincinnati Children’s Hospital Medical Center
  • Columbia University
  • Dana Farber Cancer Institute
  • Harvard University
  • Johns Hopkins University
  • Massachusetts General Hospital
  • MD Andersons Cancer Center
  • Northeastern University
  • Sinai Health System
  • Stanford Medicine
  • Sunnybrook Research Institute
  • Ohio State University
  • Tufts University
  • University of California Los Angeles Technology Development Group
  • University of California San Francisco
  • University Health Network
  • University of Florida
  • University of Massachusetts Medical School
  • Vanderbilt University
  • Vanderbilt University Medical Center
  • Weill Cornell Medicine
  • University of Calgary
  • University of Massachusetts Boston
  • University of California San Diego 

For more information about North America partnerships,